$IPAR

INTERPARFUMS INC (IPAR): Results of Operations and Financial Condition

INTERPARFUMS INC (IPAR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 7 ex991_1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INTERPARFUMS, INC. REPORTS 2026 SECOND QUARTER AND HALF YEAR RESULTS AND REAFFIRMS FULL YEAR SALES AND EARNINGS GUIDANCE Second Quarter Net Sales Rose to $341 Million with Diluted EPS of $0.95; First Half Net S

Original reporting
Published Aug 4, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$IPAR
Neutral
medium confidence
Mentioned
$IPAR
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$IPARNeutralMed
01

Why it matters

The filing updates traders on profitability trends (gross margin up slightly, operating margin down), expense drivers (marketing, royalty costs, logistics), and regional demand (North America and Asia strength versus Eastern Europe and Middle East weakness). It also provides a concrete shareholder return event via a $0.80 dividend payable Sept 30, 2026.

02

Market read

A fresh earnings-style disclosure with reaffirmed guidance and a dividend date, but with notable operating margin compression and higher marketing/logistics intensity.

03

What to watch

Organic sales were mixed (organic down 1% in Q2 and H1), and SG&A and A&P as a percent of sales rose, so traders should separate FX and comparison-base effects from underlying demand.

Relevance 7/10Novelty 7/10Timing: after-hours filing of Q2 and six-month results on Aug 4, 2026

Background

This is an SEC Form 8-K (Item 2.02) with Exhibit 99.1 reporting Interparfums’ Q2 and first-half 2026 results, commentary on regional/brand performance, and a quarterly cash dividend.

Company-level read

Ticker impact

$IPARNeutralMedium confidence
Context

Interparfums reported Q2 net sales of $341M and diluted EPS of $0.95, plus first-half results and a $0.80 quarterly dividend.

Expected impact

Likely modest, with traders focusing on operating margin compression and whether reaffirmed full-year guidance offsets margin pressure.

Evidence & confidence

Top-line grew 2% but operating income fell 17% and operating margin declined versus 2025; the filing also reiterates full-year guidance and announces a near-term dividend date, creating both upside (sales growth) and downside (margin/expense pressure) signals.

Market effects

Fragrance and branded consumer goods investors may reprice expectations for demand resilience versus geopolitical headwinds and marketing spend intensity.

Management cites Eastern Europe and Middle East/Africa weakness, implying uneven regional demand and potential FX sensitivity for peers with similar exposure.

As a global fragrance brand owner, the update reinforces that category strength can coexist with region-specific geopolitical drag.

Counterpoint

Margin compression may be temporary if inventory efficiency and mix improvements continue, making the operating income decline less alarming than it appears.

Key entities

  • Interparfums, Inc.

    Reports Q2 and six-month 2026 results, reaffirms full-year sales and earnings guidance, and declares a quarterly cash dividend.

  • Jean Madar

    Chairman and CEO providing operational commentary on brand performance, regional demand, and product extension pipeline.

  • Michel Atwood

    CFO discussing cash conversion, inventory efficiency, and expense/margin drivers.

Related articles

$IPARMed

Inter Parfums (NASDAQ:IPAR) Posts Better

Inter Parfums (NASDAQ:IPAR) reported Q2 CY2026 revenue of $341 million, up 2.1% year on year and 0.6% above market expectations, according to the company. Full-year revenue guidance was $1.48 billion at the midpoint, 1.5% below analysts’ estimates. GAAP EPS was $0.95, 2.1% below consensus. The stock was flat at $128.43 after results.

$IPARMed

INTERPARFUMS INC (IPAR): Results of Operations and Financial Condition

INTERPARFUMS INC (IPAR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 7 ex991_1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INTERPARFUMS, INC. REPORTS 2026 SECOND QUARTER NET SALES 2026 Second Quarter Conference Call Scheduled for August 5, 2026 New York, New York, July 22, 2026, Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums”

$NVDAMed

Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Broadcom, Microsoft, IBM, Meta, Tyson Foods & more

Wall Street analysts issued multiple calls Monday. Goldman initiated HawkEye 360 as buy; Morgan Stanley upgraded Dell to equal weight; Wells Fargo upgraded Tandem Diabetes Care to overweight. Citizens initiated Microsoft at Market Outperform with a $550 target; Barclays initiated IBM at overweight with a $350 target. Cantor reiterated Tesla overweight; RBC reiterated Meta outperform. Broadcom was reiterated overweight by Morgan Stanley, raising its target to $485.

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.